Fructosamine in the management of gestational diabetes
| Autor: | Alistair B. Roberts, John R. Baker, Andrew G. James, Patrick Henley |
|---|---|
| Rok vydání: | 1988 |
| Předmět: |
Blood Glucose
medicine.medical_specialty medicine.medical_treatment Birth weight Pregnancy in Diabetics Physiology Fetal Macrosomia Impaired glucose tolerance chemistry.chemical_compound Predictive Value of Tests Pregnancy Internal medicine Diabetes mellitus Prenatal Diagnosis medicine Birth Weight Humans business.industry Insulin Postpartum Period Infant Newborn Obstetrics and Gynecology Hexosamines medicine.disease Gestational diabetes Fructosamine Endocrinology chemistry Female business Postpartum period |
| Zdroj: | American journal of obstetrics and gynecology. 159(1) |
| ISSN: | 0002-9378 |
| Popis: | The role of maternal serum fructosamine estimation in the management of gestational diabetes was assessed in 78 consecutive patients over a 3-year period. Fructosamine results correlated significantly with mean plasma glucose levels over a 1- to 3-week interval, with the closest association being in the preceding week. Eighty-five percent of women with gestational diabetes had peak serum fructosamine levels above the normal range. If maternal levels exceeded 3.2 mmol/L, there was an 88% chance of abnormal glucose tolerance post partum. Our aim of management was a serum fructosamine level less than 2.5 mmol/L; patients who achieved this goal by 35 to 37 weeks' gestation had fewer obese babies with lower cord insulin and C-peptide levels as compared with neonates of mothers with elevated fructosamine concentrations. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|